GSK defends Zantac ahead of trials that have cratered the stock
admin GSK on Friday put out a statement saying there’s no link between a withdrawn heartburn…
Read MoreWholesalers
U.S. stocks end mixed as rally tied to cooler inflation data takes breather
U.S. stocks ended mostly lower on Thursday, despite hitting a three-month high early in the…
Read MoreMcDonald’s set to reopen in some cities in Ukraine — report
McDonald’s Corp. is set to reopen some of its restaurants in Ukraine, according to a…
Read MoreThese stocks soared up to 12% after inflation cooled
Amid the euphoria following what appeared to be the first sign of slowing inflation, stocks…
Read MorePrimary care has been evolving for years. Expect deals and partnerships as the market heats up
The pandemic may have taught Americans more about the potential of primary care than anything…
Read More10 defensive stocks that can also provide you with growth and dividends over the long term
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but…
Read MoreTrulieve trims view as inflation hits cannabis prospects
Trulieve Cannabis Corp. on Wednesday swung to a loss and cut its revenue outlook for…
Read MoreGet ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read MoreNovavax slashes sales guidance in half, stock plunges 34%
Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial…
Read More
These stocks soared up to 12% after inflation cooled
Amid the euphoria following what appeared to be the first sign of slowing inflation, stocks…
Read More